Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shirley0818
    Member
    • Apr 2013
    • 13

    #1

    How to merge/compare RNAseq data using different protocal

    Hello,

    I have RNA-Sequencing data generated from Illumina HT2000 for 14 samples from the same tissue. The technician applied the same protocol for these samples except for the last sequencing step by accident.

    Batch 1 (8 samples) using 50bp paired-end
    Batch 2 (6 samples) using 75bp paired-end

    Since I have to analyze these sample together, what is the best way to avoid batch effect or protocol difference and reviewer's criticism?

    Method1: align them separately, but merge them into one matrix using RPKM/FPKM for each gene and sample
    Method2: for batch2 samples, only use the first 50bp reads for alignment, ...
    Method3: re-sequencing Batch1 with 75bp paired-end protocol using the library left.

    Many thanks,
    Shirley
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    This depends on your experiment. What are you trying to measure? If it's differential expression between samples or between batch 1 and batch 2, then you can't directly compare 75bp and 50bp reads. If you just want an overall profile of the tissue type, I see no reason not to merge everything together. Also, maybe you could post a quality histogram. If the 75bp reads have terrible quality at the tail, you might not get any drawbacks from chop the reads to 50bp anyway (that's unlikely but worth mentioning). Still, read 2 in 2x75bp pairs may have slightly lower quality than read 2 in 2x50bp pairs, even after cutting everything to 50bp, which is a small but real source of possible bias.

    No matter what the experiment, Method 3 would be fine, but it's also the most costly in time and money.

    Comment

    • shirley0818
      Member
      • Apr 2013
      • 13

      #3
      Thanks Brian for your quick response. We would like to differential expression analysis,
      alternative splicing, novel transcripts, etc.

      But most importantly, in the near future, we will have 2 more batches samples, and need to be merged with these first two batches. So to be consistent and avoid potential reviewer's criticism, we would like to choose which way is the best at this early stage.

      Thanks again for your information,
      Shirley

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        If you are going to be generating more data anyway, then I'd go with method 3. It's really the only one that cannot be criticized no matter what experiment you wish to do, and for alternative splicing with RNA-seq, 75bp is much better than 50bp (though of course 100bp is better still).

        Comment

        • shirley0818
          Member
          • Apr 2013
          • 13

          #5
          Great. Thank you for your suggestions. Have a nice day!

          Comment

          • MU Core
            Member
            • Apr 2008
            • 60

            #6
            shirley0818,

            It seems that the 2x50 run was your intended sequence output. Therefore, there is no reason to repeat sequencing of your batch 2. Simply trim the 75 base reads to 50 base and the data will be directly comparable with no potential mapping bias due to longer read length.

            As an aside, the longer paired-end reads are not an advantage for the typical RNA-Seq experiment because the average insert size is ~150 bases. Therefore, a 2x100 will simply be generating overlapping reads that provide no additional advantage but significantly more cost.

            Comment

            • shirley0818
              Member
              • Apr 2013
              • 13

              #7
              Thanks MU Core.

              In our experiments, the average RNA fragments is about 200-300bp, so the 2x75bp might be better for alternative splicing as Brian suggested. we will definitely not go to 2x100 at this point due to the cost and time of resequencing both Batch1 and 2 samples.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 08-03-2026, 10:13 AM
              0 responses
              15 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              32 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              23 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-23-2026, 11:41 AM
              0 responses
              21 views
              0 reactions
              Last Post SEQadmin2  
              Working...